Related Experiment Video
Updated: Jul 7, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Medical risk analysis of renal transplant donors
I Berber1, G Tellioglu, G Kilicoglu
1Department of General Surgery and Transplantation Unit, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey. iberber@hotmail.com
Insights
Living-related kidney donation is safe, with low surgical risks and long-term health outcomes comparable to the general population. Donor nephrectomy showed minimal complications and stable renal function over time.
Area of Science:
- Nephrology
- Transplant Surgery
- Medical Ethics
Background:
- Living-related kidney donation is crucial for addressing organ shortages.
- Long-term medical risks for living donors require ongoing evaluation.
Purpose of the Study:
- To assess the long-term medical risks associated with living-related donor nephrectomy.
- Evaluate clinical and laboratory data of donors post-donation.
Main Methods:
- 185 living-related donors were followed.
- Assessed creatinine clearance rate (CrCl), serum creatinine (SCr), BUN, hematocrit, proteinuria, microalbuminuria, and hypertension.
- Evaluated renal parenchyma thickness and kidney dimensions pre- and post-donation.
Main Results:
- Low surgical morbidity with a mean hospital stay of 3.2 days.
- Postoperative complications included surgical site infections (7) and incisional herniae (4).
- Long-term follow-up (mean 61.6 months) showed stable SCr, but a decrease in CrCl (P=.03). Proteinuria and microalbuminuria were detected in some donors.
Conclusions:
- Donor nephrectomy has low surgical morbidity.
- Clinical and laboratory data are comparable to the age-matched general population.
- Long-term monitoring of renal function and detection of proteinuria/microalbuminuria are important.
Aim:
The aim of this study was to evaluate the long-term medical risks of living-related donors in our center.
Patients And Methods:
185 living-related donors participated in the study. The factors assessed were creatinine clearance rate (CrCl), serum creatinine (SCr), BUN, hematocrit levels, proteinuria, microalbuminuria and hypertension rates, and renal parenchyma thickness and kidney dimensions predonation as well as at the last follow-up. In addition, we examined postoperative complications. A lombotomy incision was the choice for donor nephrectomy procedure routinely.
Results:
The mean length of hospital stay after donor nephrectomy was 3.2 +/- 0.6 days (range, 2-5 days). Seven donors readmitted during the first month after operation with surgical site infection were treated successfully. Four donors were reoperated for incisional hernia repairs and discharged without complication. The mean follow-up period was 61.6 +/- 50.4 months (range, 2-180 months). Mean ages of the donors at operation and at the last follow-up were 50.9 +/- 12.7 years (range, 20-81 years) and 56.5 +/- 11.9 years (range, 29-77 years), respectively. The male-to-female ratio was 0.69. Mean SCr levels and CrCl rates predonation and at the last follow-up were 0.83 +/- 0.22 mg/dL versus 1.1 +/- 0.2 mg/dL (P < .001), and 103.9 +/- 28.8 mL/min versus 88.3 +/- 25.9 mL/min (P = .03), respectively. SCr levels were within normal limits in all donors at predonation and at the last follow-up. At the last follow-up, CrCl was also within expected normal limits in all donors. Hypertension was detected in 13 donors. Mean predonation and at the last follow-up renal parenchymal thickness, BUN, and hematocrit levels were similar. Kidney dimensions were significantly different at the last follow-up after donation (P = .001). Eleven donors displayed proteinuria and 19 had microalbuminuria at the last follow-up, which had been negative for all donors predonation. There were seven surgical site infections and 4 incisional herniae.
Conclusion:
Donor nephrectomy was performed with low surgical morbidity and comparable results of clinical and laboratory data to the age-matched general population.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
